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Abstract
Background: Several randomized controlled trials (RCTs) have demonstrated that intraoperative goal-directed fluid
therapy (GDFT) can decrease postsurgical complications in patients undergoing major abdominal surgery. However,
very few studies have demonstrated the value of goal-directed therapy (GDT) in patients undergoing orthopaedic
surgery and confirmed it is as useful in real-life conditions. Therefore, we initiated a GDFT implementation programme
in patients undergoing hip revision arthroplasty in order to assess its effects on postoperative complications (e.g.
infection, cardiac, neurological, renal) (primary outcome) and hospital and intensive care unit (ICU) length of stay
(secondary outcomes).
Methods: We developed a GDFT protocol for the haemodynamic management of patients undergoing hip revision
arthroplasty. The GDFT protocol was based on continuous monitoring and optimization of stroke volume during the
surgical procedure. From December 2012 and for a period of 17 months, 130 patients were treated according to the
GDFT protocol (GDFT group). The pre-, intra-, and postoperative characteristics of patients from the GDFT group were
compared to those of 130 historical matched patients (control group) who had the same surgery between January
2011 and August 2012.
Results: Patients from the GDFT and from the control group were comparable in terms of age, comorbidities, and
P-POSSUM score. Duration of anaesthesia and surgery were also comparable. The GDFT group had a significantly
lower morbidity rate (49.2 vs. 66.9%; p = 0.006) and a shorter median hospital length of stay (11 days (9–15) vs.
9 days (8–12); p = 0.003) than the control group. Patients from the control group post-anaesthesia care unit
(PACU)/ICU stayed significantly longer at PACU/ICU than patients from the GDFT group (control group vs. GDFT
group, 960 min (360–1210) vs. 400 min (207–825); p < 0.001) Patients from the GDFT group received less crystalloids
but more colloids during surgery. They also received more often inotropic therapy.
Conclusions: In patients undergoing hip revision arthroplasty, the implementation of GDT as a new standard
operating procedure was successful and associated with reduced postsurgical complications, most importantly a
reduction in postoperative bleeding as well as hospital and ICU stay.
Trial registration: ClinicalTrials.gov, NCT01753050
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Background
More than 230 million major surgical procedures are
undertaken every year worldwide (Weiser et al. 2008). The
most operations were performed under general anaesthe-
sia. A survey in 2013 in the UK showed over 2,766,600
general anaesthesia during 1 year (Sury et al. 2014).
Morbidity rates >25% have repeatedly been reported
after major surgery (Ghaferi et al. 2009). Therefore,
strategies to improve outcome and prevent postopera-
tive complications are required in surgical patients.
Many randomized controlled trials (RCTs) and meta-
analysis suggest that perioperative goal-directed fluid
therapy (GDFT) decreases postsurgical complications
and length of hospital stay in patients undergoing major
abdominal procedures (Benes et al. 2010; Gan et al.
2002; Grocott et al. 2012; Hamilton et al. 2011; Lopes et
al. 2007). However, (1) larger and multicentre studies
have yielded conflicting results (Pearse et al. 2014;
Pestaña et al. 2014; Scheeren et al. 2013). Pearse et al.
demonstrated in their randomized trial of high-risk
patients undergoing major gastrointestinal surgery that
the use of a cardiac output-guided haemodynamic
therapy algorithm when compared did not significantly
reduce postoperative complications and 30-day mortal-
ity (Pearse et al. 2014); (2) RCTs are done in highly
selected patients with extra human and financial
resources, such that the extrapolation of their results to
the real world may be questioned (Vincent 2009); and
(3) only a few studies have been done in orthopaedic
patients and none in patients undergoing hip revision
arthroplasty. Patients undergoing revision hip surgery
are usually old and often have comorbidities, increasing
their risk of complications after surgery.
Therefore, we made the decision to implement GDFT
in patients undergoing hip revision arthroplasty and to
assess its effects on postoperative outcome as an en-
hanced recovery project for these patients.
Methods
Study outline
We enrolled prospectively 130 patients over a period of
17 months (from December 1, 2012, to April 30, 2014)
who were managed according to our GDFT protocol
(GDFT group). All consecutive patients admitted for re-
vision hip surgery were screened for inclusion. Inclusion
criteria were age ≥18 years and one of the following sur-
gical procedures (hip revision arthroplasty): hip revision
with change of the prosthesis, explantation of existing
hip arthroplasty, or patients after Girdlestone resection
arthroplasty, who underwent new implantation of hip
prosthesis. Patients from the GDFT group were compared
to 130 historical matched control patients (control group)
who underwent the same surgical procedure from January
1, 2011, to August 30, 2012, before we developed the
algorithm for the prospective group. During this time
frame, no patients were treated with additional monitoring
that could measure intraoperative stroke volume.
The study protocol was registered at ClinicalTrials.gov
(NCT01753050) and approved by the ethics committee
at Charité – Universitätsmedizin Berlin (EA1/315/12).
Informed written consent was obtained from all prospect-
ive GDFT patients. Retrospective patients (control group)
provided their consent to use their data in anonymized
fashion for scientific purposes by signing the treatment
contract with our university hospital. The study was
performed at the Charité – University hospital Berlin,
Campus Charité Mitte. Stroke volume monitors were
loaned by Edwards Lifesciences, which had no role in the
development of the study protocol and the data analysis.
Patient management
All patients underwent general anaesthesia during sur-
gery. Anaesthesia was induced according to our written
SOP with fentanyl (1–2 μg kg−1), propofol (1–2 mg kg−1),
and cisatracurium (0.15 mg kg−1). After endotracheal in-
tubation, the maintenance of anaesthesia was performed
at the discretion of the attending anaesthesiologist with
either sevoflurane or propofol continuously. Fentanyl and
cisatracurium boli were given as needed.
Standard monitoring in both groups included electro-
cardiogram, pulse oximetry, temperature, and inspiratory
and expiratory gas concentrations as well as monitoring
of depth of anaesthesia. In the retrospective group, the
choice between non-invasive or invasive blood pressure
measurement was at the discretion of the attending an-
aesthesiologist. None of the patients from the retrospect-
ive group was monitored with a device that was able to
measure stroke volume (SV) or any other flow-related
parameter. In all patients of the GDFT group, invasive
blood pressure was monitored via right or left radial
artery. Haemodynamic optimization in this group was
done as follows: SV was monitored using a pulse con-
tour method (Vigileo 03.06, Edwards Lifesciences, Irvine,
CA, USA) and a special pressure transducer (FloTrac
system, Edwards Lifesciences). Baseline SV was mea-
sured after induction of anaesthesia and patient position-
ing. An intravenous colloid bolus of 250 mL (Volulyte®
6%, Fresenius Kabi Deutschland GmbH, Bad Homburg,
Germany, or Gelafundin ISO 40 mg mL−1, B. Braun
Melsungen AG, Melsungen, Germany) was given within
5 min and repeated until reaching a SV plateau value
(increase in SV < 10%). The optimum stroke volume
(SVopt) was defined as the last successful fluid challenge,
e.g. the last SV value just before reaching the plateau
value, and SVtrigger as SVopt minus 10%. Our GDT proto-
col is shown in Fig. 1. During surgery, our goal was to
maintain SV above SVtrigger using fluid boluses, or ino-
tropes (dobutamine or enoximone at 3 μg kg−1 h−1),
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when fluid loading was unable to restore SV values above
SVtrigger. Inotropes were not used in patients with two or
more of the following conditions: existing coronary heart
disease or angina pectoris, presence of diabetes mellitus,
impaired renal function, or stroke in the patient’s history
(Kristensen et al. 2014). Compliance to the haemodynamic
treatment protocol was monitored using case report forms
(CRFs) and evaluated postoperatively by two independent
anaesthesiologists. Disagreement, if any, was solved by dis-
cussion with a third anaesthesiologist. The compliance
rate was calculated as the number of protocol deviations
divided by the total number of interventions during sur-
gery and expressed as a percentage.
In the control group, haemodynamic management was
left at the discretion of the attending anaesthesiologist.
Outcome variables
The primary outcome measurement was the proportion of
patients developing one or more postoperative complica-
tions during the hospital stay. All complications were ex-
tracted retrospectively from the electronic patient database
management system by an independent medical documen-
tation assistant, both for the GDFT and the control group
using ICD-10-coded diagnoses in the medical records. The
following postoperative complications were considered for
analysis: infectious complications (wound infections,
wound healing disturbances, pneumonia, urinary tract
infections, sepsis, endocarditis, and peritonitis); cardiac
complications (arrhythmias requiring medical treatment,
pulmonary oedema, pulmonary embolism, myocardial in-
farction, and cardiovascular arrest); neurological complica-
tions (postoperative delirium and postoperative stroke);
renal complications (increase of creatinine above twofold
before surgery or need for dialysis); and haemorrhagic
complications (postoperative bleeding with the need for
postoperative red blood cell (RBC) transfusion).
Secondary outcome variables were postoperative need
for vasopressors, postoperative complications, length of
stay in the recovery room, post-anaesthesia care unit
(PACU) or intensive care unit (ICU), the total length of
hospital stay after surgery, and hospital mortality.
Statistical analysis
Due to deviations from the normal distribution
(Kolmogorov-Smirnov test), all analyses were per-
formed non-parametrically. Results were expressed as
median with 25th to 75th percentiles. Mann-Whitney
U test and exact Fisher’s test were used for inter-group
differences. Absolute and relative frequencies were used
for categoric and dichotomous variables. Statistical ana-
lysis was carried out by using the Software Package for
Social Sciences, 22.0 SPSS® for Macintosh (SPSS, Inc.,
Chicago, IL). A p value <0.05 was considered statisti-
cally significant.
The demographics and baseline covariates used for
matching the GDFT group with an historical group were
the age, the ASA score, and the P-POSSUM score,
which are variables known to be independent predictors
of postoperative morbidity and mortality. The ASA score
and the P-POSSUM score were different between the
groups when we analysed all the patients (GDFT group
(n = 130) vs. control group (n = 258)) in favour of the
control group. Several matching methods were excised
in this study in order to find optimal balance using the
identified baseline covariates. As a result, the individual
matching method was chosen for this study and per-
formed with the R package “optmatch” version 0.9-1.29
(Hansen and Klopfer 2006).
Results
Between December 1, 2012, and April 30, 2014, 130 pa-
tients were recruited as part of the prospective GDFT
Fig. 1 Graphical representation of our GDFT protocol. Fluid was administered until stroke volume reached a plateau value (SVmax). The optimum
SV (SVopt) value was the last value preceding SVmax. SV trigger (SVtrigger) was calculated as SVopt minus 10%. Additional colloid boluses were
administered only when SV was below SVtrigger
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group. Two hundred and fifty-eight patients underwent
hip revision arthroplasty surgery between 1/2011 and
08/2012, and 130 were finally used for analysis and com-
parison after matching (Fig. 2).
The basic characteristics from patients (before matching)
showed significant difference regarding the ASA score and
the P-POSSUM score between the groups (Additional
file 1: Table S1). The matching was performed using
different parameters (age, ASA score and P-POSSUM
score) to achieve equal distributions of the basic charac-
teristics and the perioperative risk factors.
Before surgery, the matched patients from the GDFT
group and from the control group were comparable
(Table 1).
During surgery, the GDFT protocol was properly
followed 87.3% of the time. The overall fluid balance was
comparable in both groups (Table 2). However, the
GDFT group received more colloids and less crystalloids
than the control group (Table 2). The GDFT group
received more inotropes but not more vasopressors
than the control group (Table 2).
Outcome variables
The postoperative morbidity rate was significantly lower
in the GDFT group than in the control group (49.2 vs.
66.9%, p = 0.006) (Table 3). Postoperative LOS was sig-
nificantly shorter in the GDFT group (11 days (9–15) vs.
9 days (8–12); p = 0.003) (Fig. 3). When patients were
admitted in the ICU postoperatively, the patients from
the control group stayed significantly longer in the ICU
than the patients from the GDFT group (control group
vs. GDFT group, 960 min (360–1210) vs. 400 min (207–
825); p < 0.001). Other outcome variables are reported in
Table 3 and Fig. 4.
Nevertheless, patients of the GDT group had signifi-
cantly less postoperative cardiac complications (control
group vs. GDT group, 7.7 vs. 1.5%; p = 0.034) (Table 3),
especially as the new arrhythmias postoperatively
occurred significantly more often in the control group
(control group vs. GDT group, 6.9 vs. 0.8%; p = 0.019).
The mortality rate was comparable between the groups
(control group vs. GDT group, 0.8% (1) vs. 0.8% (1);
1.000).
Discussion
In this matched cohort study and quality improvement
project, we implemented into clinical routine a goal-
directed fluid therapy protocol in patients undergoing
revision hip surgery. The implementation was successful
with a high protocol compliance rate of 87%. Patients
from the GDFT had a significantly reduced postopera-
tive morbidity (relative decrease of 26.5% (p = 0.006)), as
well as a 2-day shorter length of hospital stay (p = 0.003)
and also a shorter ICU stay (p < 0.001, when the patients
were admitted to the ICU postoperatively).
Many studies have demonstrated the ability of GDFT
to improve postoperative outcome in patients undergo-
ing major abdominal and vascular procedures. Recent
meta-analysis of randomized controlled trials (RCTs)
suggests a 25–50% reduction in postoperative morbidity
that was associated with a 1–2-day reduction in hospital
length of stay (Grocott et al. 2012; Hamilton et al. 2011;
Pearse et al. 2014). However, only few studies were done
in patients undergoing orthopaedic surgery. In 1996,
Sinclair et al. showed in 40 patients undergoing repair of
proximal femoral fractures that fluid loading to an opti-
mal stroke volume resulted in a more rapid postopera-
tive recovery and a significantly reduced hospital stay
Fig. 2 Flowchart recruitment HIPHOP
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(Sinclair et al. 1997). In 2002, Venn et al. showed that an
invasive intraoperative haemodynamic monitoring
concept using fluid challenges during repair of femoral
fracture reduced the recovery time and also length of
hospital stay (Venn et al. 2002). More recently, Cecconi
et al. reported that in patients undergoing primary hip
replacement under regional anaesthesia a goal-directed
haemodynamic therapy changes the intraoperative fluid
management and reduces postoperative complications
(p = 0.05) (Cecconi et al. 2011). As far as we know, our
study is the first investigating the effects of GDFT in pa-
tients undergoing more complex hip revision surgery.
In sharp contrast to this overwhelming evidence coming
from RCTs, only little attention has been put on clinical
implementation at the bedside and the value of GDFT in
real life. Kuper et al. published in 2011 a multicentre trial
where they implemented GDFT into clinical practice. In
spite of a lower than expected (65%) adoption rate during
the implementation phase, they observed a significantly
shorter length of hospital stay with GDFT. Cannesson et
al. recently published another real-life implementation
programme of GDFT in patients undergoing major ab-
dominal procedures and observed a 14% decrease in post-
operative morbidity associated with decrease in median
hospital length of stay from 10 (6–16) days to 7 (5–11)
days (p = 0.0001) (Cannesson et al. 2015). In line with
these publications, our study shows that implementation
of GDFT is not only possible in a tertiary university med-
ical centre but also might be beneficial for patients in
whom the postoperative morbidity rate decreased by
26.5% and hospital length of stay decreased from 11 (9–
15) days to 9 (8–12) days during the implementation
phase. Our protocol was pretty simple and part of a newly
created standard operating procedure officially approved
by the departments of anaesthesiology and orthopaedic
surgery. Both factors may have contributed to the high
compliance rate and the clinical benefits we observed.
One point of discussion is the increased use of inotropes
during surgery that might put the GDFT patients at an in-
creased risk of myocardial ischemia and other cardiac com-
plications. In contrast, the incidence of arrhythmia was
significantly reduced in the GDFT group. The risk of myo-
cardial ischemia and cardiac complications might have been
mitigated by the fact that we used the risk assessment algo-
rithm from the ESA/ESC to prevent patients being treated
systematically with inotropes that are at high risk for myo-
cardial ischemia (Kristensen et al. 2014). The adequate use
of inotropes during surgery, based on SV data, may be
helpful without increasing myocardial complications.
This is in line with a recent meta-analysis which
showed that the use of GDFT is associated with a de-
crease and not an increase in cardiac complications and
in particular arrhythmias which are often triggered by
hypovolemia (Arulkumaran et al. 2014). Other under-
lying factors that might have contributed to the re-
duced rate of cardiovascular complications might have
been an improved microvascular perfusion leading to
reduced systemic inflammation (Jhanji et al. 2010).






Age (years) 72 (60–76) 71 (62–75) 0.643
Sex (w/m) 86/44 81/49 0.440
Body height (cm) 166 (160–171) 168 (163–175) 0.155
Body weight (kg) 76 (65–85) 79 (64–90) 0.177
BMI kg/m2 27.36 (24.69–30.06) 27.77 (23.80–32.11) 0.658
CCS 3 (2–5) 3 (2–4) 0.249
ASA score 2 (2–3) 2 (2–3) 0.730
P-POSSUM score 27.00 (23.00–31.00) 29.00 (24.00–33.00) 0.102
Parameters are shown as median and (25th percentile–75th percentile). CCS:
The Charlson Comorbidity Score includes age, previous myocardial infarction
or congestive heart failure, peripheral vascular disease, cerebrovascular
disease, existing dementia, COPD, connective tissue disease, peptic ulcer
disease, diabetes mellitus, moderate to severe chronic kidney disease,
hemiplegia, leukaemia, malignant lymphoma, solid tumour, liver disease, and
AIDS. Different points were distributed for the pre-existing diseases, and so,
the survival rate during the first 2 years can be calculated






Anaesthesia time (min) 185 (160–230) 197 (170–254) 0.056
Surgery time (min) 125 (99–159) 135 (107–171) 0.111
Total fluid (mL) 2210 (1658–3000) 2435 (1760–3480) 0.139
Crystalloids (mL) 1500 (1000–2000) 725 (500–1000) <0.001
Colloids (mL) 500 (500–1000) 1250 (1000–1750) <0.001
Inotropes 1 [0.8] 28 [21.5] <0.01
Blood transfusion 47 [36.2] 57 [43.8] 0.255
NE at end of surgery 18 [13.8] 10 [7.7] 0.160
Admission recovery room 75 [57.7] 71 [54.6] 0.708
Admission PACU 44 [33.8] 53 [40.8] 0.305
Admission ICU 11 [8.5] 6 [4.6] 0.316
Parameters are shown as median (25th percentile–75th percentile) and
number [percentage]
NE norepinephrine, ICU intensive care unit, PACU post-anaesthesia care unit






Total morbidity 87 [66.9%] 64 [49.2%] 0.006
Infectious complications 13 [10%] 10 [7.7%] 0.663
Cardiac complications 10 [7.7%] 2 [1.5%] 0.034
Postoperative arrhythmia 9 [6.9%] 1 [0.8%] 0.019
Neurological complications 6 [4.6%] 7 [5.4%] 1.000
Renal complications 2 [1.5%] 2 [1.5%] 1.000
Hemorrhagic complications 80 [61.5%] 56 [43.1%] 0.004
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Fig. 3 Postoperative hospital length of stay
Fig. 4 Postoperative complications
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Another interesting finding was the reduced transfusion
rate after surgery seen in the GDFT group. We did not
change our transfusion guidelines during the study period,
so it is unlikely that a change in transfusion practice could
have explained it. It could be speculated that due to an im-
proved intraoperative microcirculation in the optimized
group, early bleeding during surgery is better recognized
by the surgeon, and therefore, surgical haemostasis might
be performed more effectively preventing later bleeding
complications. Nevertheless, this is speculative and needs
to be reproduced by further research.
Our study has several limitations. Given its before-
after design, we cannot claim causality between the GDFT
intervention introduced as a new standard of care and the
observed changes in postoperative outcome. However,
RCTs also have their limitations, particularly when blind-
ing is not possible, as is the case when studying changes in
clinical behaviour. Indeed, when performing a RCT where
fluid management is standardized by the use of a prede-
fined treatment protocol, clinicians are inevitably sensibi-
lized and trained about the risk of giving too little or too
much fluid during the perioperative period. As a result,
they may change their usual practice and the so-called
control group may not reflect anymore what used to be
standard management in their institution. This “training
effect” will tend to decrease the likelihood to show a dif-
ference between the intervention and the control group.
On the other hand, when performing RCTs, clinicians
usually benefit from extra human and financial resources,
helping them to ensure the new strategy is properly imple-
mented. This “resource effect” tends in contrast to in-
crease the probability to show a difference between
groups. In our study, the fluid management of the histor-
ical control group was not influenced at all by GDFT
training and use since we introduced it only at the end of
2012. And when GDFT was introduced, it was used for all
patients undergoing hip revision surgery as part of a new
standard operating procedure. As a result, we believe our
quality improvement study provides a pretty fair idea of
the impact of GDFT implementation in real-life condi-
tions and is complementary of previous RCTs done in
orthopaedic patients, showing a benefit in more con-
trolled conditions.
Conclusions
In patients undergoing hip revision arthroplasty, the
implementation of GDFT was associated with a signifi-
cant decrease in postoperative morbidity and hospital
length of stay. Our study confirms in real-life conditions
what previous RCTs had suggested and is a clear invita-
tion to expand our implementation to other surgical
patient populations in whom postoperative complica-
tions remain an issue.
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